Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Detrusor Hyperreflexia of Bladder”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)Study completedNCT01600716
What this trial is testing

Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)

Who this might be right for
Urinary IncontinenceMultiple SclerosisNeurogenic Bladder
Allergan 144
Post-approval studies (Phase 4)Study completedNCT00224016
What this trial is testing

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Who this might be right for
Detrusor Hyperreflexia
Watson Pharmaceuticals 57
Not applicableStudy completedNCT03388086
What this trial is testing

Efficacy of Two Onabotulinum Toxin Doses

Who this might be right for
Neurogenic BladderOveractive Detrusor
Swiss Paraplegic Research, Nottwil 56
Testing effectiveness (Phase 2)Ended earlyNCT01598103
What this trial is testing

Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

Who this might be right for
Neurogenic Urinary BladderNeurogenic Bladder DisorderNeurogenic Dysfunction of the Urinary Bladder+2 more
Novartis Pharmaceuticals 9
Post-approval studies (Phase 4)UnknownNCT03755089
What this trial is testing

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

Who this might be right for
Overactive Bladder SyndromeUrge IncontinenceUrinary Incontinence+2 more
Women and Infants Hospital of Rhode Island 110
Large-scale testing (Phase 3)Study completedNCT01530620
What this trial is testing

Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Urinary Bladder DisorderUrinary Bladder, NeurogenicBladder Disorder, Neurogenic+6 more
APOGEPHA Arzneimittel GmbH 66
Large-scale testing (Phase 3)UnknownNCT03758235
What this trial is testing

Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin

Who this might be right for
Overactive Bladder Syndrome
University Of Perugia 140
Post-approval studies (Phase 4)Ended earlyNCT01796548
What this trial is testing

Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity

Who this might be right for
Detrusor Function, Overactive
Janssen-Cilag Ltd.,Thailand 17
Not applicableStudy completedNCT01226706
What this trial is testing

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Who this might be right for
Urinary Urge Incontinence
Saskatchewan Health Authority - Regina Area 21
Not applicableWithdrawnNCT01043848
What this trial is testing

Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients

Who this might be right for
Neurogenic Detrusor OveractivitySpinal Cord Injury
Ulrich Mehnert
Large-scale testing (Phase 3)Ended earlyNCT02660138
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 227
Not applicableStudy completedNCT02590250
What this trial is testing

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Who this might be right for
Urinary IncontinenceOveractive Bladder
Allergan 250
Testing effectiveness (Phase 2)Study completedNCT00857896
What this trial is testing

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Pfizer 21
Post-approval studies (Phase 4)Study completedNCT00224029
What this trial is testing

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Who this might be right for
Detrusor Hyperreflexia
Watson Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT01557244
What this trial is testing

Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 181
Large-scale testing (Phase 3)Ended earlyNCT02660359
What this trial is testing

Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2

Who this might be right for
Urinary IncontinenceOveractive Bladder
Ipsen 258
Large-scale testing (Phase 3)Active Not RecruitingNCT05621616
What this trial is testing

Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Global Development, Inc. 7
Large-scale testing (Phase 3)Study completedNCT02501928
What this trial is testing

Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

Who this might be right for
Urinary Bladder, Neurogenic
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT02849418
What this trial is testing

Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity

Who this might be right for
Urinary Bladder, Overactive
GlaxoSmithKline 21
Not applicableStudy completedNCT03063827
What this trial is testing

Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients

Who this might be right for
Neurogenic Bladder
Buddhist Tzu Chi General Hospital 36
Load More Results